pharmaceutical plant affected its storage facility, rather than its medicine production areas, the company said Friday.
“We do not expect there to be any immediate significant impacts on supply given the products are currently at hospitals and in the distribution system,” U.S. Food and Drug Administration Commissioner Robert Califf said Friday. Pfizer said Friday that a warehouse for raw materials, packaging supplies and finished medicines awaiting release had endured most of the damage to its 1.4 million square foot plant. An initial inspection by the company found no major damage to its medicine manufacturing areas, and all 3,200 local employees are safe and accounted for.Pfizer Chairman and CEO Dr.
Nous avons résumé cette actualité afin que vous puissiez la lire rapidement. Si l'actualité vous intéresse, vous pouvez lire le texte intégral ici. Lire la suite: